Mochida Pharmaceutical Co (FRA:MFY) Net Change in Cash : €0.0 Mil (TTM As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Mochida Pharmaceutical Co Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Mochida Pharmaceutical Co's Net Change in Cash for the three months ended in Dec. 2023 was €0.0 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 was €0.0 Mil.

Mochida Pharmaceutical Co Net Change in Cash Historical Data

The historical data trend for Mochida Pharmaceutical Co's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mochida Pharmaceutical Co Net Change in Cash Chart

Mochida Pharmaceutical Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Net Change in Cash

Get a 7-Day Free Trial

18.99

24.71

-3.62

-17.50

-84.25

Mochida Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Change in Cash	Get a 7-Day Free Trial															-	-	-	-	-

Mochida Pharmaceutical Co Net Change in Cash Calculation

Mochida Pharmaceutical Co's Net Change in Cash for the fiscal year that ended in Mar. 2024 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-45.933	+	0.454	+	-39.258	+	0.485
	=	-84.3

Mochida Pharmaceutical Co's Net Change in Cash for the quarter that ended in Dec. 2023

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= 0 + 0 + 0 + 0

= 0.0

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mochida Pharmaceutical Co Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Mochida Pharmaceutical Co's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Mochida Pharmaceutical Co (FRA:MFY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mochida Pharmaceutical Co Ltd (FRA:MFY) » Definitions » Net Change in Cash

Comparable Companies

TSE:4521 TSE:4551 TSE:4569 TSE:4553 TSE:4547 TSE:4559 TSE:4506 TSE:4886 TSE:2929 TSE:4577 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692

Traded in Other Exchanges

4534:Japan

Address

1-1 Ichigayahonmuracho, Shinjuku-ku, Tokyo, JPN, 162-0845

Website

http://www.mochida.co.jp

Mochida Pharmaceutical Co Ltd is a major drug manufacturing company that operates in the field of medical care through its pharmaceuticals, healthcare products, and medical equipment businesses. The company's pharmaceuticals business aims to develop and market a broad spectrum of innovative new drugs. One of Mochida's main objectives is to maximize the business performance of its drugs after they are developed and released. The company also creates skin care products for the general public, and these are supplied through pharmacies, drugstores, and mail-order sales.

Mochida Pharmaceutical Co (FRA:MFY) Headlines

No Headlines